Extract
Obstructive sleep apnoea (OSA) is increasingly recognised as a risk factor for stroke [1]. However, the incidence of stroke in patients investigated for OSA has been assessed in a limited number of studies reporting conflicting results on the association between the apnoea–hypopnoea index (AHI) and stroke incidence [1–3].
Abstract
Indices of sleep apnoea-related hypoxic burden and heart rate variability derived from full-night polysomnography might be useful for identifying sleep apnoea patients at risk for stroke https://bit.ly/3eIYVsc
Acknowledgements
We thank the French National Health Insurance for giving us access to the French administrative health care database. We thank the ERMES study group: Centre Hospitalier Universitaire, Angers: Christine Person, Pascaline Priou; Centre Hospitalier, Le Mans: Olivier Molinier, Audrey Paris. We thank Christelle Gosselin and Jean-Louis Racineux from the Institut de Recherche en Santé Respiratoire des Pays de le Loire. We thank Julien Godey, Laetitia Moreno and Marion Vincent, sleep technicians in the Dept of Respiratory and Sleep Medicine of Angers University Hospital.
Footnotes
Conflict of interest: M. Blanchard has nothing to disclose.
Conflict of interest: C. Gervès-Pinquié has nothing to disclose.
Conflict of interest: M. Feuilloy has nothing to disclose.
Conflict of interest: M. Le Vaillant has nothing to disclose.
Conflict of interest: W. Trzepizur has nothing to disclose.
Conflict of interest: N. Meslier has nothing to disclose.
Conflict of interest: F. Goupil has nothing to disclose.
Conflict of interest: T. Pigeanne has nothing to disclose.
Conflict of interest: F. Balusson has nothing to disclose.
Conflict of interest: E. Oger has nothing to disclose.
Conflict of interest: A. Sabil has nothing to disclose.
Conflict of interest: J-M. Girault has nothing to disclose.
Conflict of interest: F. Gagnadoux reports grants and personal fees from Resmed, personal fees and non-financial support from Sefam, Novartis and Air Liquide Sante, personal fees from Cidelec and Actelion, non-financial support from Boehringer Ingelheim and Asten, outside the submitted work.
Support statement: This study was supported by a grant from the Pays de la Loire Respiratory Health Research Institute (IRSR), Beaucouzé, France. Funding information for this article has been deposited with the Crossref Funder Registry.
- Received September 23, 2020.
- Accepted November 2, 2020.
- Copyright ©ERS 2021
LIBRARY USERS
Log in through your institution
Purchase access
